Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.

CONTEXT A decrease in pancreatic β-cell mass is involved in the development of type 2 diabetes. OBJECTIVE The purpose of this study was to evaluate the β-cell mass and the incidence of β-cell neogenesis, replication, and apoptosis at both the prediabetic and diabetic stages. METHODS We conducted a cross-sectional study of pancreatic tissues obtained from 42 patients undergoing a pancreatectomy who were classified into 4 groups: normal glucose tolerance (n = 11), impaired glucose tolerance (n = 11), newly diagnosed diabetes (n = 10), and long-standing type 2 diabetes (n = 10). RESULTS The relative β-cell area decreased and the β-cell apoptosis increased during the development of diabetes. The number of single and clustered β-cells, some of which coexpressed nestin, increased in the patients with impaired glucose tolerance and newly diagnosed diabetes. The prevalence of cells positive for both insulin and glucagon or somatostatin also increased in these patients compared with those with normal glucose tolerance. These double-positive cells were mainly localized in single and clustered β-cells, rather than large islets, and were also positive for Pdx1 or Ngn3. The percentage of insulin-positive cells embedded within ducts increased in the impaired glucose tolerance group. There were no significant differences in the incidence of cells positive for both insulin and Ki67 among the groups. CONCLUSIONS These results suggest that β-cell neogenesis, rather than replication, predominates during impaired glucose tolerance and newly diagnosed diabetes in humans and may serve as a compensatory mechanism for the decreased β-cell mass.

[1]  T. Sanke,et al.  International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values , 2012, Diabetology International.

[2]  G. Warnock,et al.  Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas , 2012, Diabetologia.

[3]  W. Uhl,et al.  Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans , 2012, Diabetologia.

[4]  S. Kahn,et al.  β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. , 2011, The American journal of pathology.

[5]  C. Cobelli,et al.  Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes , 2011, Diabetes.

[6]  M. Sander,et al.  Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas , 2011, Development.

[7]  J. Pankow,et al.  Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans , 2011, Diabetes.

[8]  S. Bonner-Weir,et al.  Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats , 2010, Journal of Cell Science.

[9]  C. Cobelli,et al.  Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy , 2010, Diabetologia.

[10]  L. Rosenberg,et al.  {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. , 2010, Endocrinology.

[11]  C. Sergi,et al.  Beta-cell development and turnover during prenatal life in humans. , 2010, European journal of endocrinology.

[12]  P. Herrera,et al.  Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss , 2010, Nature.

[13]  L. Bouwens,et al.  Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. , 2009, Developmental cell.

[14]  C. Ricordi,et al.  Endocrine Cell Clustering During Human Pancreas Development , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  W. Uhl,et al.  Functional Assessment of Pancreatic β-Cell Area in Humans , 2009, Diabetes.

[16]  C. Sempoux,et al.  Pancreatic β‐cell mass in European subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[17]  G. Sisino,et al.  Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity , 2008, Diabetologia.

[18]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[19]  M. Wheeler,et al.  Transcription factor expression in the developing human fetal endocrine pancreas , 2008, Diabetologia.

[20]  R. Scharfmann,et al.  β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.

[21]  W. Uhl,et al.  Partial Pancreatectomy in Adult Humans Does Not Provoke β-Cell Regeneration , 2008, Diabetes.

[22]  Y. Matsuzawa,et al.  Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment , 2005, Diabetologia.

[23]  Y. Yamasaki,et al.  Beta-cell regeneration in a patient with type 1 diabetes mellitus who was receiving immunosuppressive therapy. , 2003, Annals of internal medicine.

[24]  Y. Matsuzawa,et al.  Analysis of Expression Profiles of Islet-associated Transcription and Growth Factors During &bgr;-Cell Neogenesis from Duct Cells in Partially Duct-ligated Mice , 2003, Pancreas.

[25]  B. Pakkenberg,et al.  Increased islet volume but unchanged islet number in ob/ob mice. , 2003, Diabetes.

[26]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[27]  Y. Matsuzawa,et al.  Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. , 2001, Diabetes.

[28]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[29]  J. Habener,et al.  Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. , 2001, Diabetes.

[30]  KS Polonsky,et al.  Dynamics of insulin secretion in obesity and diabetes , 2000, International Journal of Obesity.

[31]  S. Bonner-Weir,et al.  The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. , 1999, Diabetes.

[32]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[33]  L. Bouwens,et al.  Extra-insular beta cells associated with ductules are frequent in adult human pancreas , 1998, Diabetologia.

[34]  Y. Matsuzawa,et al.  Demonstration of Two Different Processes of β-Cell Regeneration in a New Diabetic Mouse Model Induced by Selective Perfusion of Alloxan , 1997, Diabetes.

[35]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[36]  L. Baxter,et al.  A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development , 1993, Diabetes.

[37]  E. Montanya,et al.  Pancreatic remodeling: beta-cell apoptosis, proliferation and neogenesis, and the measurement of beta-cell mass and of individual beta-cell size. , 2009, Methods in molecular biology.

[38]  A. Basu,et al.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. , 2009, The Lancet. Oncology.

[39]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.